Partial anomalous pulmonary venous connection pathophysiology

Revision as of 16:55, 2 November 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Partial anomalous pulmonary venous connection Microchapters

Home

Patient Information

Overview

Anatomy

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Differentiating Partial anomalous pulmonary venous connection from other Diseases

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Partial anomalous pulmonary venous connection pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Partial anomalous pulmonary venous connection pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Partial anomalous pulmonary venous connection pathophysiology

CDC on Partial anomalous pulmonary venous connection pathophysiology

Partial anomalous pulmonary venous connection pathophysiology in the news

Blogs on Partial anomalous pulmonary venous connection pathophysiology

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Partial anomalous pulmonary venous connection pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]

Overview

A congenital heart disease, like partial anomalous pulmonary venous connection, directly influences the normal mechanical, physical and biomechanical functioning of the heart. Partial anomalous pulmonary venous connection involves an exceeding ratio of the pulmonary blood flow to systemic blood flow.

Pathophysiology

The most important determinant of the ratio of pulmonary blood flow (Qp) to systemic flow (Qs) (the Qp/Qs ratio or the magnitude of the shunt) is the number of pulmonary veins that drain into the RA. The greater the number of pulmonary veins that drain into the [[RA}}, the greater the magnitude of the shunt. It has been speculated that when the proportion of returning pulmonary veins that drain anomalously exceeds 50% of the pulmonary veins, then the anomaly is clinically significant. The position of the patient relative to the position of the anomalous pulmonary veins may also influence the magnitude of shunting. If a patient is standing, pulmonary blood flow is predominantly to the middle and the lower lobes of the lung. If there are a greater proportion of anomalous veins draining these portions of the lung, then standing can exacerbate the shunt. Other noncardiac conditions may influence the magnitude of shunting. One such disease state is the scimitar syndrome or pulmonary venolobar syndrome. In scimitar syndrome there is abnormal right-sided pulmonary venous drainage into the inferior vena cava. There is also malformation and/or hypoplasia of the right lung along with anomalous arterial flow to the right lung.

References

Template:WH Template:WS